Complement 5a Receptor Antagonist
- Name
- Complement 5a Receptor Antagonist
- Accession Number
- DBCAT005653
- Description
Not Available
- Drugs
Drug Drug Description Avacopan An orally bioavailable complement 5a receptor (C5aR) antagonist for the treatment of severe anti-neutrophil cytoplasmic (auto)antibody (ANCA)-associated vasculitis. - Drugs & Drug Targets
Drug Target Type Avacopan C5a anaphylatoxin chemotactic receptor 1 target Avacopan Cytochrome P450 3A4 enzyme Avacopan P-glycoprotein 1 transporter Avacopan Cytochrome P450 1A2 enzyme Avacopan Cytochrome P450 2B6 enzyme Avacopan Cytochrome P450 2C9 enzyme